Replies to post #2418 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

oldberkeley,

I wouldn't call it as much 'poor trading' as I would call it an missed opportunity. The confusion lies in the difference of how we price momenta versus the street's valuation. Sadly, the street normally wins.

I did sell in the 20's only to repurchase too soon afterwards. I can't stress enough that I think the Pharma's and Bio's are valued on their future hopes and dreams rather than their balance or income statements.